Nora Henrikson, PhD, MPH, conducts research that seeks to improve the lives of people with cancer and their families. Her current projects include interventions to mitigate cancer-related financial hardship and to improve communication with families about genetic risk. In addition, she leads KPWA’s participation in the Kaiser Permanente Evidence-Based Practice Center.
Dr. Henrikson joined Kaiser Permanente Washington Health Research Institute as a research associate in 2010.
Social/behavioral quantitative and qualitative research; intervention design; systematic review and evidence synthesis; epidemiology; patient-provider communication
Genetic testing for cancer risk, cancer-related financial hardship
Social, ethical, and policy implications of genomics and precision health
Henninger ML, Mcmullen CK, Firemark AJ, Naleway AL, Henrikson NB, Turcotte JA. User-centered design for developing interventions to improve clinician recommendation of human papillomavirus vaccination. Perm J. 2017;21. doi: 10.7812/TPP/16-191. PubMed
Naber SK, Kuntz KM, Henrikson NB, Williams MS, Calonge N, Goddard KAB, Zallen DT, Ganiats TG, Webber EM, Janssens ACJW, van Ballegooijen M, Zauber AG, Lansdorp-Vogelaar I. Cost effectiveness of age-specific screening intervals for people with family histories of colorectal cancer. Gastroenterology. 2018 Jan;154(1):105-116.e20. doi: 10.1053/j.gastro.2017.09.021. Epub 2017 Sep 28. PubMed
Henrikson NB, Chang E, Ulrich K, King D, Anderson ML. Communication with physicians about health care costs: survey of an insured population. Perm J. 2017;21. doi: 10.7812/TPP/16-070. PubMed
Henrikson NB, Anderson ML, Opel DJ, Dunn J, Marcuse EK, Grossman DC. Longitudinal trends in vaccine hesitancy in a cohort of mothers surveyed in Washington state, 2013-2015. Public Health Rep. 2017 Jan 1:33354917711175. doi: 10.1177/0033354917711175. [Epub ahead of print]. PubMed
Henrikson NB, Tuzzio L, Gilkey MB, McRee AL. "You're never really off time": healthcare providers' interpretations of optimal timing for HPV vaccination. Prev Med Rep.doi:10.1016/j.pmedr.2016.05.002. [Epub ahead of print].
Parchman ML, Henrikson NB, Blasi PR, Buist DS, Penfold R, Austin B, Ganos EH. Taking action on overuse: creating the culture for change. Healthc (Amst). 2016 Nov 10. pii: S2213-0764(16)30167-1. doi: 10.1016/j.hjdsi.2016.10.005. [Epub ahead of print]. PubMed
Henrikson NB, Lau RW, Tuzzio L, Christianson M, Phan TH, Chen E. Treatment prices at the point of care in a clinical oncology service: pilot project. J Oncol Pract. 2016 Oct;12(10):e957-e963. PubMed
Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock EP. Lipid screening in childhood and adolescence for detection of familial hypercholesterolemia: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016 Aug 9;316(6):645-55. doi: 10.1001/jama.2016.6176. PubMed
Lozano P, Henrikson NB, Morrison CC, Dunn J, Nguyen M, Blasi PR, Whitlock EP. Lipid screening in childhood and adolescence for detection of multifactorial dyslipidemia: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016 Aug 9;316(6):634-44. doi: 10.1001/jama.2016.6423. PubMed
Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Blasi PR. Screening for skin cancer in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA.2016;316(4):436-447. doi:10.1001/jama.2016.5415. PubMed
Dr. Henrikson’s Annals of Internal Medicine study describes 3 kinds of cost concerns that can affect cancer care.
Nora Henrikson discusses her latest research published in the Annals of Internal Medicine in May 2019. (Vimeo, 3:50)
Leah Tuzzio, MPH, and colleagues describe an underutilized role that can help primary care become truly patient-centered.
Avalere podcast, Feb. 22, 2019